Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage
KH Maniar, IA Jones, R Gopalakrishna… - Expert opinion on …, 2018 - Taylor & Francis
KH Maniar, IA Jones, R Gopalakrishna, CT Vangsness Jr
Expert opinion on pharmacotherapy, 2018•Taylor & FrancisIntroduction: Osteoarthritis is a burdensome disease that causes progressive damage to
articular cartilage. Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the preferred
treatments for symptomatic relief. However, NSAIDs can cause serious dose-dependent side
effects, which has prompted experts to recommend the minimization of NSAID dosage.
Areas covered: This review focuses on three broad strategies that are currently being
investigated or implemented to minimize NSAID dosage: nano-formulation, encapsulation …
articular cartilage. Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the preferred
treatments for symptomatic relief. However, NSAIDs can cause serious dose-dependent side
effects, which has prompted experts to recommend the minimization of NSAID dosage.
Areas covered: This review focuses on three broad strategies that are currently being
investigated or implemented to minimize NSAID dosage: nano-formulation, encapsulation …
Abstract
Introduction: Osteoarthritis is a burdensome disease that causes progressive damage to articular cartilage. Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the preferred treatments for symptomatic relief. However, NSAIDs can cause serious dose-dependent side effects, which has prompted experts to recommend the minimization of NSAID dosage.
Areas covered: This review focuses on three broad strategies that are currently being investigated or implemented to minimize NSAID dosage: nano-formulation, encapsulation, and topical delivery. The benefits, challenges and current status of these methods are discussed.
Expert opinion: Multiple strategies are under investigation to lower NSAID dosage. There is great potential in developing formulations that utilize more than one of these strategies together. However, there are challenges to developing these lower dose preparations.
In order to maximize the clinical potential of the abundance of NSAIDs that are both available and being developed, there is a major need for additional clinical studies directly comparing safety and efficacy of different preparations.
Taylor & Francis Online以上显示的是最相近的搜索结果。 查看全部搜索结果